Yi-Li Chen - Search Results

Year	Number of Results
2006	1
2007	1
2008	1
2009	1
2010	2
2011	4
2012	2
2013	3
2014	2
2015	2
2016	2
2020	3
2021	7
2022	12
2023	7
2024	2

1

Ma LF, Chen YL, Shan WG, Zhan ZJ. Ma LF, et al. Among authors: chen yl. Nat Prod Rep. 2020 Jul 1;37(7):999-1030. doi: 10.1039/c9np00062c. Epub 2020 Feb 27. Nat Prod Rep. 2020. PMID: 32104815 Review.

2

Natural product-derived ferroptosis mediators.

Chen YL, Xiong LA, Ma LF, Fang L, Zhan ZJ. Chen YL, et al. Phytochemistry. 2024 Mar;219:114002. doi: 10.1016/j.phytochem.2024.114002. Epub 2024 Jan 27. Phytochemistry. 2024. PMID: 38286199 Review.

3

Dual-target Bridging ELISA for Bispecific Antibodies.

Pei M, Wang Y, Tang L, Wu W, Wang C, Chen YL. Pei M, et al. Among authors: chen yl. Bio Protoc. 2022 Oct 5;12(19):e4522. doi: 10.21769/BioProtoc.4522. eCollection 2022 Oct 5. Bio Protoc. 2022. PMID: 36313202 Free PMC article.

4

Functions of Sphingolipids in Pathogenesis During Host-Pathogen Interactions.

Wang J, Chen YL, Li YK, Chen DK, He JF, Yao N. Wang J, et al. Among authors: chen yl. Front Microbiol. 2021 Aug 2;12:701041. doi: 10.3389/fmicb.2021.701041. eCollection 2021. Front Microbiol. 2021. PMID: 34408731 Free PMC article. Review.

5

Orosomucoid proteins limit endoplasmic reticulum stress in plants.

Wang LY, Li J, Gong B, Wang RH, Chen YL, Yin J, Yang C, Lin JT, Liu HZ, Yang Y, Li J, Li C, Yao N. Wang LY, et al. Among authors: chen yl. New Phytol. 2023 Nov;240(3):1134-1148. doi: 10.1111/nph.19200. Epub 2023 Aug 22. New Phytol. 2023. PMID: 37606093

6

Chemotherapeutic Drug-Regulated Cytokines Might Influence Therapeutic Efficacy in HCC.

Wang CI, Chu PM, Chen YL, Lin YH, Chen CY. Wang CI, et al. Among authors: chen yl. Int J Mol Sci. 2021 Dec 20;22(24):13627. doi: 10.3390/ijms222413627. Int J Mol Sci. 2021. PMID: 34948424 Free PMC article. Review.

7

Bispecific antibody targeting both B7-H3 and PD-L1 exhibits superior antitumor activities.

Li HY, Chen YL, Deng XN, Li HH, Tan J, Liu GJ, Zheng YJ, Pei M, Peng KT, Yue LL, Chen XJ, Liu Y, Zhao YS, Wang CH. Li HY, et al. Among authors: chen yl. Acta Pharmacol Sin. 2023 Nov;44(11):2322-2330. doi: 10.1038/s41401-023-01118-2. Epub 2023 Jun 16. Acta Pharmacol Sin. 2023. PMID: 37328649

8

Roles of protein tyrosine phosphatases in hepatocellular carcinoma progression (Review).

Chen YL, Hsieh CC, Chu PM, Chen JY, Huang YC, Chen CY. Chen YL, et al. Oncol Rep. 2023 Mar;49(3):48. doi: 10.3892/or.2023.8485. Epub 2023 Jan 20. Oncol Rep. 2023. PMID: 36660927 Free PMC article. Review.

9

PD-L1/TIGIT bispecific antibody showed survival advantage in animal model.

Mu S, Liang Z, Wang Y, Chu W, Chen YL, Wang Q, Wang G, Wang C. Mu S, et al. Among authors: chen yl. Clin Transl Med. 2022 May;12(5):e754. doi: 10.1002/ctm2.754. Clin Transl Med. 2022. PMID: 35522941 Free PMC article. No abstract available.

10

HER2/PD1 bispecific antibody in IgG4 subclass with superior anti-tumour activities.

Chu W, Xu H, Wang Y, Xie Y, Chen YL, Tan X, Huang C, Wang G, Wang Q, Luo W, Xia N, Geng M, Xie Z, Wang C. Chu W, et al. Among authors: chen yl. Clin Transl Med. 2022 Apr;12(4):e791. doi: 10.1002/ctm2.791. Clin Transl Med. 2022. PMID: 35384333 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

48 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year